There are industries, you see, that defy common sense. They’re like those persistent garden weeds that flourish even after you’ve sworn vengeance upon them with fire and brimstone. Tobacco, dear reader, is one such industry. Despite the best efforts of public health officials (and the increasingly pointed stares of anyone with lungs), it persists. Altria Group (MO 0.15%) and Philip Morris International (PM +0.14%), once siblings in the art of persuading people to inhale burning leaves, now stand as separate, rather magnificent, behemoths. Both still reliably deliver dividends, which, let’s be honest, is the sort of dependable magic most investors crave.
Since their amicable parting in 2008 (a split rumored to have involved a particularly heated argument over the proper shade of packaging), both companies have been attempting to reinvent themselves. The current trend? Anything but cigarettes. It’s like watching alchemists desperately trying to turn lead into… well, something slightly less likely to give you a cough that sounds like a disgruntled badger.
The question, then, isn’t whether tobacco will vanish (it won’t, trust me), but which of these titans will navigate the shifting sands of habit and regulation with the most… finesse. And, more importantly, which one will deliver a return that doesn’t require selling your grandmother’s silverware.
Smoke-free products will become increasingly important
Cigarettes, you see, are a remarkably sticky product. Not in the pleasant, honey-based way, but in the ‘once you’re hooked, good luck escaping’ kind of way. Altria has, for decades, managed to offset the inevitable decline in cigarette sales with price increases. It’s a bit like a magician subtly relieving you of your wallet while you’re admiring the doves. They’re a ‘Dividend King,’ boasting over fifty years of uninterrupted dividend growth. A feat of financial necromancy, if you ask me.
Philip Morris, on the other hand, has always had a wider view, a larger playground. They enjoyed a substantial international market, though admittedly one with its own set of challenges (varying regulations, cultural preferences, the occasional pirate). But they didn’t just sit back and count their profits. They took a gamble, a rather large one, on new products. The Iqos heated tobacco device, launched over a decade ago, was a bold move. And then, in 2022, they acquired Swedish Match, the makers of Zyn, a nicotine pouch that’s rapidly becoming the darling of those seeking a smoke-free fix. It’s like watching a seasoned gambler double down on a promising hand.
Currently, smoke-free products account for a significant 41.5% of Philip Morris’s total net sales. Altria, meanwhile, remains stubbornly reliant on the old ways, a bit like a knight insisting on fighting dragons with a toothpick.
What makes Philip Morris the winner
Altria’s Marlboro brand is, frankly, astonishing. It’s resilient to a degree that borders on the supernatural. Investors shouldn’t panic just yet. But they should be aware that time is not on their side. They have time to establish themselves in the smoke-free space, yes, but they need to prove they can do it. Their foray into the world of Juul was, shall we say, a spectacular miscalculation. And their On! nicotine pouch brand, while respectable, lags far behind Zyn in the U.S. market. It’s the difference between a well-trained warhorse and a slightly confused pony.
Philip Morris, however, has a years-long track record of successfully rolling out Iqos in international markets and is now bringing it to the United States. Zyn, despite facing competition, remains the industry leader and is growing at an impressive rate. It’s like watching a master craftsman honing their skills, while their competitor is still trying to figure out which end of the hammer to hold.
If Altria doesn’t make meaningful progress with a viable cigarette alternative – a heated tobacco device, a vaping system, something – in the next few years, Iqos and other smoke-free products could seriously undermine their core business. A decline in cigarette volume could quickly turn things upside down. It’s a bit like building a magnificent castle on a foundation of sand.
Right now, Philip Morris has a clear competitive advantage in the smoke-free arena, positioning them well for the long term. Until Altria Group can deliver tangible results outside its core business, investing in Philip Morris is, quite simply, the more sensible option. It’s not about predicting the future, you see. It’s about recognizing which horse is most likely to cross the finish line. And in this race, Philip Morris is currently wearing the silks.
Read More
- 20 Movies Where the Black Villain Was Secretly the Most Popular Character
- Top 20 Dinosaur Movies, Ranked
- Silver Rate Forecast
- Can AI Lie with a Picture? Detecting Deception in Multimodal Models
- 25 “Woke” Films That Used Black Trauma to Humanize White Leads
- 22 Films Where the White Protagonist Is Canonically the Sidekick to a Black Lead
- Top 10 Coolest Things About Invincible (Mark Grayson)
- When AI Teams Cheat: Lessons from Human Collusion
- From Bids to Best Policies: Smarter Auto-Bidding with Generative AI
- Unmasking falsehoods: A New Approach to AI Truthfulness
2026-03-24 09:52